German-born cancer biologist Hans-Guido Wendel is taking advantage of transformative advances in genomics technology to understand key genetic abnormalities in leukemia and lymphoma.

Memorial Sloan-Kettering scientists, physicians, and administrators are developing and commercializing research discoveries to generate more-effective and affordable cancer treatments.

Scientists have generated a compound that could potentially be used to create a new type of pain medication that may prevent the side effects of currently available painkillers.

Memorial Sloan-Kettering medical oncologist Clifford A. Hudis has been elected President of the American Society of Clinical Oncology, the world’s leading professional organization representing more than 30,000 physicians who care for people with cancer.

Memorial Sloan-Kettering notes with sadness the death of Lloyd J. Old, who was internationally recognized as one of the founders and standard bearers of the field of tumor immunology.

This holiday season, we encourage Facebook fans to interact with us through our new Giving tab! You can make a donation, post a support or survivor badge on your wall for your friends to see, sign up to receive our supporter e-newsletter, learn about ways to get involved, and read stories featuring community fundraising events.